Bottom line
VHCIX vs JEHSX: the short answer
VHCIX (Vanguard Health Care Index Fund) and JEHSX (Health Sciences Trust) are both mutual funds.
But VHCIX is far broader, holding 407 positions to 173 for JEHSX, so beyond the top names it adds exposure JEHSX doesn't have.
VHCIX is cheaper at 0.09% vs 1.04% — a difference of $95 a year per $10,000 invested.
Over five years, VHCIX returned +7.2% a year vs +4.2% for JEHSX (reporting dates differ).
Updated Nov 19, 2026
VHCIX vs JEHSX side by side
| VHCIX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Vanguard | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 1.04% |
| Annual cost per $10k | $9 | $104 |
| 10-yr cost on $10k (prospectus) | $115 | $1,282 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | +2.7% | +19.5% |
| 5-yr return (annualized) | +7.2% | +4.2% |
| 10-yr return (annualized) | +8.8% | +8.7% |
| Best quarter | +16.5% | +23.6% |
| Worst quarter | −13.1% | −16.1% |
| Net assets (fund) | $19.0B | $251.3M |
| Number of holdings | 407 | 173 |
| Portfolio turnover | 4% | 68% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHCIX | JEHSX | Difference |
|---|---|---|---|
| 2024 | +2.7% | +1.8% | +0.9% |
| 2023 | +2.5% | +4.3% | −1.8% |
| 2022 | −5.5% | −13.1% | +7.6% |
| 2021 | +20.5% | +11.2% | +9.3% |
| 2020 | +18.2% | +27.2% | −8.9% |
| 2019 | +22.0% | +28.7% | −6.7% |
| 2018 | +5.6% | +0.7% | +4.9% |
| 2017 | +23.4% | +27.5% | −4.2% |
| 2016 | −3.3% | −10.6% | +7.2% |
Source: Fund prospectus bar charts
Holdings overlap
16 of VHCIX's top 25 holdings also appear in JEHSX's top 25.
| Holding | VHCIX | JEHSX |
|---|---|---|
| Eli Lilly & Co | 14.04% | 14.30% |
| Johnson & Johnson | 8.47% | 6.33% |
| AbbVie Inc | 6.09% | 5.28% |
| UnitedHealth Group Inc | 5.45% | 5.95% |
| Merck & Co Inc | 4.66% | 4.21% |
| Thermo Fisher Scientific Inc | 2.93% | 2.67% |
| Amgen Inc | 2.87% | 1.90% |
| Gilead Sciences Inc | 2.64% | 2.95% |
| Intuitive Surgical Inc | 2.38% | 1.98% |
| Abbott Laboratories | 2.35% | 2.00% |
| Bristol-Myers Squibb Co | 1.84% | 2.22% |
| Danaher Corp | 1.84% | 1.51% |
| CVS Health Corp | 1.83% | 0.98% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.38% |
| Stryker Corp | 1.66% | 1.87% |
Source: SEC Form N-PORT
VHCIX top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between VHCIX and JEHSX?
Which is cheaper, VHCIX or JEHSX?
Should I own both VHCIX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.